Information  X 
Enter a valid email address

Puretech Health PLC Ord 1P (PRTC)

Date Time Source Announcement
15 Jan 2020 1:04 pm
RNS
Akili's New ADHD Trial Met Primary Endpoint
13 Jan 2020 12:07 pm
RNS
Second Price Monitoring Extn
  12:02 pm
RNS
Price Monitoring Extension
02 Jan 2020 7:00 am
RNS
Total Voting Rights
19 Dec 2019 7:00 am
RNS
Follica Positive Androgenetic Alopecia Study
17 Dec 2019 12:00 pm
RNS
Gelesis Partners with US Telehealth Provider
12 Dec 2019 1:04 pm
RNS
Akili Meets Primary Endpoint in MDD Clinical Trial
10 Dec 2019 12:02 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
Vedanta & BMS Begin Immuno-Oncology Clinical Study
09 Dec 2019 7:00 am
RNS
Gelesis Attracts $84M in New Capital for Launch
05 Dec 2019 7:00 am
RNS
Vedanta MultiDrug Resistance Program Granted $5.8M
02 Dec 2019 7:00 am
RNS
Total Voting Rights
25 Nov 2019 12:02 pm
RNS
Price Monitoring Extension
21 Nov 2019 7:00 am
RNS
Karuna Prices $250M Follow-On Offering
18 Nov 2019 11:03 am
RNS
Karuna Successful Ph2 Schizophrenia Study Readout
15 Nov 2019 12:51 pm
RNS
resTORbio Update on Phase 3 Trial
13 Nov 2019 7:00 am
RNS
PureTech to Present at Jefferies London Conference
05 Nov 2019 1:00 pm
RNS
PRTC Presents Novel Oncology Program Data at SITC
  11:00 am
RNS
Gelesis Shares New Plenity Safety & Efficacy Data
28 Oct 2019 12:07 pm
RNS
Second Price Monitoring Extn
  12:02 pm
RNS
Price Monitoring Extension
24 Oct 2019 7:00 am
RNS
Sonde Names Healthcare Tech Exec David Liu as CEO
18 Oct 2019 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
04 Oct 2019 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  12:07 pm
RNS
Second Price Monitoring Extn
  12:02 pm
RNS
Price Monitoring Extension
02 Oct 2019 7:00 am
RNS
Minority Stake Acquisition & PDMR Notification
01 Oct 2019 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  1:15 pm
RNS
Vor Appoints Senior Cell & Gene Therapy Leaders
  7:00 am
RNS
Total Voting Rights
23 Sep 2019 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  12:07 pm
RNS
Second Price Monitoring Extn
  12:02 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
Vedanta Expands Series C with $62.1M Total Raised
16 Sep 2019 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
09 Sep 2019 12:07 pm
RNS
Second Price Monitoring Extn
  12:02 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
PureTech Announces Board Change
06 Sep 2019 4:41 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
04 Sep 2019 12:07 pm
RNS
Second Price Monitoring Extn
  12:02 pm
RNS
Price Monitoring Extension
27 Aug 2019 7:00 am
RNS
PureTech Health plc Half-Year Report
20 Aug 2019 7:00 am
RNS
Notice of Results
19 Aug 2019 12:02 pm
RNS
Price Monitoring Extension
14 Aug 2019 5:30 pm
RNS
BTG
07 Aug 2019 1:40 pm
RNS
Vor Names Biotech Vet Robert Ang President & CEO
01 Aug 2019 7:00 am
RNS
Total Voting Rights
31 Jul 2019 1:40 pm
RNS
Vor Biopharma Adds R&D Leader Bill Lundberg to BOD
17 Jul 2019 7:00 am
RNS
PRTC Acquires Clinical Stage Asset for Lymphedema
11 Jul 2019 7:00 am
RNS
Potential US Listing of PureTech Health on Nasdaq
09 Jul 2019 7:00 am
RNS
PRTC Immuno-Oncology Programme Granted US Patent
03 Jul 2019 7:00 am
RNS
PRTC's Karuna closes IPO, gross proceeds $102.6M
01 Jul 2019 7:00 am
RNS
First Patient in Vedanta Food Allergy Study
 
Headlines
Top categories

21-Jan-2020 10:10 AM

Broker Forecast - Jefferies International issues a broker note on Dechra Pharmaceuticals PLC

Jefferies International today downgrades its investment rating on Dechra Pharmaceuticals PLC (LON:DPH) to hold (from buy) and cut its price target to ...

Company finder

a d v e r t i s e m e n t